- Report
- September 2024
- 136 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- March 2025
- 200 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- May 2025
- 197 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- January 2023
- 115 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- July 2022
- 257 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Report
- October 2023
- 133 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- August 2023
- 106 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- July 2023
- 153 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- February 2023
- 86 Pages
Global
From €3500EUR$4,186USD£3,088GBP

The Infant Phototherapy Device market is a segment of the Medical Devices industry that focuses on the treatment of newborns with jaundice. Phototherapy is a non-invasive procedure that uses light to reduce the level of bilirubin in the blood. Infant Phototherapy Devices are designed to provide a safe and effective treatment for newborns with jaundice. These devices typically include a light source, a timer, and a light shield to protect the infant's eyes.
Infant Phototherapy Devices are used in hospitals, neonatal intensive care units, and other healthcare settings. They are designed to be easy to use and provide a safe and effective treatment for newborns with jaundice.
Some companies in the Infant Phototherapy Device market include Philips Healthcare, GE Healthcare, Dräger Medical, Natus Medical, and BiliBlanket. Show Less Read more